An investigational noninvasive urine biomarker is being evaluated for the detection of urothelial carcinoma in patients with asymptomatic microscopic hematuria. Epidemiological data indicates that the prevalence of urothelial carcinoma in the target demographic (adults aged 50-70 with isolated microscopic hematuria) is .
Validation studies of the new biomarker demonstrate a sensitivity of and a specificity of for detecting urothelial carcinoma.
A 62-year-old man with asymptomatic microscopic hematuria undergoes testing with this new urine biomarker, and the result is positive.
Based on these test characteristics, what is the probability (in percentage) that this patient actually has urothelial carcinoma?
Cevap: 25 %
Cevap
The probability that the patient actually has urothelial carcinoma is 25%.
The positive predictive value (PPV) is heavily influenced by the prevalence of the disease in the population being tested. Despite a seemingly high sensitivity (80%) and specificity (90%), the low prevalence (4%) means that the absolute number of healthy individuals is vastly larger than the number of diseased individuals. Consequently, the 10% false positive rate generates a large number of false positive results (960) that outnumber the true positive results (320). Therefore, the probability that a positive test indicates true disease is only 320 / 1280, or 25%.
Adım Adım Çözüm
Anahtar Kavram
Positive Predictive Value (PPV) dependence on disease prevalence
Alternatif Yöntem
This can also be solved using Likelihood Ratios (LR). Pretest Probability = 0.04, so Pretest Odds = 0.04 / 0.96 = 1/24. The Positive Likelihood Ratio (LR+) = Sensitivity / (1 - Specificity) = 0.80 / 0.10 = 8. Post-test Odds = Pretest Odds × LR+ = (1/24) × 8 = 1/3. Converting back to probability: Post-test Probability = Odds / (1 + Odds) = (1/3) / (4/3) = 1/4 = 25%.
Tahmini Süre:1m 30s